GLP-1 and GIP inhibitors are amazing medications at doing what they were developed for managing blood sugar in people with type 2 diabetes and weight loss in obesity, study co-author Kelly Allison, a professor of psychiatry and director of the Center for Weight and Eating Disorders at Penn, said in the news release
This foundational step helps identify any potential contraindications before a prescription is even considered
Yes its common for one breast to lose more volume or sag more than the other after significant weight loss, since fat loss and skin changes dont always happen equally on both sides
Tirzepatide and Dual Compound Options for Midwest Patients Beyond semaglutide, PlexusDx provides compounded tirzepatide injections at $289/mo month-to-month, or from $249/mo on the 6-month plan for Midwest residents in Illinois, Ohio, Michigan, and Indiana who seek dual GLP-1 and GIP receptor agonism
The most common adverse reactions reported in clinical trials include gastrointestinal symptoms (nausea, vomiting, diarrhea, constipation), which occurred in a substantial proportion of patients but are generally transient
Who Are Good Candidates
